Equities
Health CareMedical Equipment and Services
  • Price (DKK)172.85
  • Today's Change6.85 / 4.13%
  • Shares traded831.53k
  • 1 Year change+9.40%
  • Beta1.2266
Data delayed at least 15 minutes, as of Apr 19 2024 15:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GN Store Nord A/S is a Denmark-based company offering audio solutions. The Company is focused on human auditory system, sound and speech, wireless technologies, and software development linking insight and knowledge from both the hearing aid and the headset industries. The Company's segments include GN Hearing, GN Audio and Other GN. The GN Audio segment is engaged in selling hands free communications solutions in the form of headsets for mobile phones and traditional phones. The GN Hearing segment operates within the hearing instrument industry, primarily producing and selling hearing instruments and related products. GN Hearing is a wholesale manufacturer. It offers a portfolio of medical, professional and consumer audio solutions, and offers brands in the medical technology, hearables and audio fields. Its audio solutions are marketed by its brands ReSound and Jabra. It provides products and solutions to users in over 90 countries across the world.

  • Revenue in DKK (TTM)18.12bn
  • Net income in DKK228.00m
  • Incorporated--
  • Employees7.17k
  • Location
    GN Store Nord A/SLautrupbjerg 7BALLERUP 2750DenmarkDNK
  • Phone+45 45750000
  • Fax+45 45750009
  • Websitehttps://www.gn.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Synsam AB (publ)3.79bn199.38m5.12bn3.41k25.493.147.561.352.092.0939.6216.960.73562.2213.121,730,149.003.86--5.27--75.50--5.25--0.4922--0.5675--11.90---5.18------
Xvivo Perfusion AB383.09m58.87m6.48bn160.00104.605.2066.6416.923.073.0719.9561.750.30421.236.203,734,638.004.671.235.021.3374.4973.1415.374.765.09--0.01590.0043.8826.04398.2948.5721.35--
Arjo AB (publ)7.04bn308.37m7.70bn6.80k26.771.707.821.091.771.7740.3127.840.69914.456.571,615,181.003.043.554.275.5543.1344.014.355.410.70933.830.419843.0110.035.976.9010.15-8.8910.35
Biotage AB1.19bn157.71m8.39bn674.0050.333.5833.297.033.253.2525.1645.710.51221.926.852,762,611.006.7710.748.0012.7761.7161.3413.2115.771.4332.640.066140.1118.9015.37-8.217.9714.051.30
Embla Medical hf5.51bn409.30m12.65bn4.00k30.482.5316.602.300.97050.970513.1311.710.57962.246.541,377,213.004.344.065.174.7661.8062.477.486.911.226.680.39883.999.335.0937.34-6.056.50--
Elekta AB (publ)11.68bn918.70m17.72bn4.58k20.042.8010.911.523.743.7447.6026.820.62083.292.904,150,570.004.894.328.697.8937.9039.937.887.680.82194.020.410665.7915.957.83-18.28-6.9012.8611.38
GN Store Nord A/S18.12bn228.00m25.05bn7.17k108.422.5212.561.381.531.53130.4365.840.59192.964.282,528,960.000.86884.911.577.4449.5553.291.476.820.48121.880.584736.84-3.0311.30-55.38-28.747.53--
Ambu A/S4.90bn238.00m25.62bn4.70k120.985.3643.145.230.90140.901418.7120.360.70752.007.261,060,875.003.443.813.974.6256.9759.374.865.431.307.200.103822.897.4512.8880.65-13.006.67--
Getinge AB20.40bn1.55bn34.20bn11.74k23.711.9013.101.688.858.85116.85110.750.60272.745.782,711,219.004.605.316.096.9845.5447.837.648.690.77614.050.209937.8712.495.66-3.17---0.394434.49
Demant A/S22.44bn2.55bn68.76bn21.62k27.197.41--3.0611.448.05100.5841.970.74312.055.881,037,923.008.468.2712.2013.2373.7274.1411.3811.340.95295.980.60750.0013.8910.0012.236.968.80--
Data as of Apr 19 2024. Currency figures normalised to GN Store Nord A/S's reporting currency: Danish Krone DKK

Institutional shareholders

22.41%Per cent of shares held by top holders
HolderShares% Held
Norges Bank Investment Managementas of 13 Dec 20237.39m4.90%
APG Asset Management NVas of 21 Nov 20226.85m4.54%
The Vanguard Group, Inc.as of 05 Apr 20245.31m3.52%
FIL Investments Internationalas of 29 Feb 20242.73m1.81%
DWS Investment GmbHas of 29 Feb 20242.21m1.46%
Oddo BHF Asset Management SASas of 29 Feb 20242.09m1.38%
Dimensional Fund Advisors LPas of 04 Apr 20241.95m1.29%
Handelsbanken Fonder ABas of 31 Mar 20241.90m1.26%
BlackRock Fund Advisorsas of 04 Apr 20241.88m1.25%
Nordea Investment Management AB (Denmark)as of 29 Feb 20241.51m1.00%
More ▼
Data from 31 Dec 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.